Debates between Sajid Javid and Ronnie Cowan during the 2019 Parliament

Oral Answers to Questions

Debate between Sajid Javid and Ronnie Cowan
Tuesday 14th June 2022

(1 year, 10 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Sajid Javid Portrait Sajid Javid
- View Speech - Hansard - -

The right hon. Gentleman will know that I have visited the site and spoken to local members of the trust. It is a project that we support, and we are in the final stages of the final approvals.

Ronnie Cowan Portrait Ronnie Cowan (Inverclyde) (SNP)
- View Speech - Hansard - - - Excerpts

As was pointed out by the hon. Member for Lichfield (Michael Fabricant), this Government promised medical cannabis on the NHS 1,183 days ago. Since then, a child with epilepsy will have experienced, at a modest estimate, 35,490 seizures. We have free NHS prescriptions, which proves that the medicine exists and is approved for use in the United Kingdom. How much longer must those children suffer?

Oral Answers to Questions

Debate between Sajid Javid and Ronnie Cowan
Tuesday 1st March 2022

(2 years, 2 months ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Ronnie Cowan Portrait Ronnie Cowan (Inverclyde) (SNP)
- View Speech - Hansard - - - Excerpts

The Secretary of State is on record saying:

“Making medicinal cannabis available on prescription will benefit the lives of ill patients currently suffering in silence. There is nothing harder than seeing your loved ones in pain”.

Since he said that, there have been three prescriptions for medical cannabis on the NHS. They are important, because they set a legal and medical precedent that it can happen, and it can happen now. Currently, however, if I can afford it, I can buy it, but if I cannot, I cannot. When will he address that anomaly?

Sajid Javid Portrait Sajid Javid
- View Speech - Hansard - -

The hon. Gentleman will know that for medicines to be generally available on the NHS, they have to be deemed safe and effective by the independent medical regulator. That requires trials to take place and that is where the focus should be. Those who want those medicines to be more easily available should encourage the companies that produce them to have trials and the NHS will support them in doing so.